Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Arrowhead Pharmaceuticals, Inc. company logo
Arrowhead Pharmaceuticals, Inc. logo

Arrowhead Pharmaceuticals, Inc. (ARWR)

Profile

Company profile for Arrowhead Pharmaceuticals, Inc. (ARWR)
MetricValue
Full NameArrowhead Pharmaceuticals, Inc.
TickerNASDAQ: ARWR
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CountryUnited States
IPO
IndexesNot included
Websitearrowheadpharma.com
Employees609

Key Metrics

Arrowhead Pharmaceuticals, Inc. Key Details
MetricDateValue
Price$65.93
Price, 1D Change+2.12%
Market Cap$9B
-
PE Ratio-
Beta1.77
Revenue$829M
Revenue, 1Y Change+23,258.15%
EPS-$0.01
EPS, 1Y Change+99.76%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Arrowhead Pharmaceuticals, Inc. chart

Events

Arrowhead Pharmaceuticals, Inc. Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last Split1:10
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

ARWR Estimates
MetricDateValue
EPS-$0.01
EPS EstimateN/A-$3.46
EPS Est. ChangeN/A-28,252.46%
Revenue$829.45M
Revenue EstimateN/A$389.56M
Revenue Est. ChangeN/A-53.03%
Current Price$65.93
Price Target-$81.00
Price Tgt. Change-+22.86%

🔒 Log In To Unlock Full Data

EPS

ARWR EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
-$4.53-$5.00-10.53%
-$0.03-$0.01+63.69%
-$3.46N/A-28,252.46%
-$4.54N/A-37,092.62%
ARWR EPS reported versus estimate values chart

Revenue

ARWR revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$61.60M$3.55M-94.24%
$757.44M$829.45M+9.51%
$389.56MN/A-53.03%
$276.56MN/A-66.66%
ARWR revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

ARWR Performance
MetricDateValue
Price, 1Y+256.57%
Price, 3Y+82.38%
Market Cap, 1Y+294.57%
Market Cap, 3Y+137.67%
Revenue, 1Y+23,258.15%
Revenue, 3Y+241.01%
EPS, 1Y+99.76%
EPS, 3Y+99.27%

🔒 Log In To Unlock Full Data

Technical Indicators

ARWR Technical Indicators
MetricDateValue
Current Price$65.93
SMA 200$29.69
SMA 200 vs Price-54.97%
SMA 50$56.34
SMA 50 vs Price-14.54%
Beta1.77
ATR$4.50
14-Day RSI53.63
10-Day Volatility79.37%
1-Year Volatility73.12%

Dividends

ARWR Dividends
MetricDateValue
N/A-
UpcomingN/AN/A
-
-
Dividends Paid$0.00
Payout Ratio0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

ARWR Income & Profitability
MetricDateValue
Revenue$829.45M
EPS-$0.01
Gross Profit$805.52M
Gross Margin97.12%
Operating Profit$98.35M
Operating Margin11.86%
Net Income$30.11M
Net Margin3.63%
EBITDA$122.27M

🔒 Log In To Unlock Full Data

Financial Health

ARWR Financial Health
MetricDateValue
Debt To Equity1.57
Current Ratio4.86
Quick Ratio4.86
-
F-Score-
Altman Z-Score5.65

Valuations

ARWR Valuations
MetricDateValue
PE Ratio-
PS Ratio11.04
PB Ratio19.66
EV/EBITDA73.40
Enterprise ValueN/A-

Balance Sheet

ARWR Balance Sheet
MetricDateValue
Book Value$466.05M
Cash & Equivalents$919.37M
Total Assets$1.45B
Current Assets$950.64M
Total Liabilities$947.02M
Current Liabilities$195.49M
Total Debt$733.68M
Short Term Debt$47.29M
Accounts Payable$17.67M

Expenses

ARWR Expenses
MetricDateValue
Total Expenses$831.08M
Operating Expenses$707.17M
Cost Of Goods Sold$23.93M
SG&A$0.00
D&A$23.93M
Interest Expense$0.00
Income Tax$21.42M

Cash Flow

ARWR Cash Flow
MetricDateValue
CFO$179.55M
CFI-$129.29M
CFF$74.01M
Capex$22.67M
Free Cash Flow$156.89M

Recent analyst updates

ARWR Recent analyst updates
MetricDateValue
Morgan Stanley→
Goldman Sachs→
Chardan Capital→
Piper Sandler→
RBC Capital→
B of A Securities→
HC Wainwright & Co.→
Chardan Capital→
B of A Securities→
Morgan Stanley→

Analyst sentiment

Sentiment over the past month
ARWR analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
ARWR institutional ownership distribution chart

Screeners with ARWR

Data Sources & References

  1. ARWR Official Website arrowheadpharma.com
  2. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/879407/000087940725000029/0000879407-25-000029-index.htm
  3. ARWR Profile on Yahoo Finance finance.yahoo.com/quote/ARWR
  4. ARWR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/arwr

FAQ

  • What is the ticker symbol for Arrowhead Pharmaceuticals, Inc.?

    The ticker symbol for Arrowhead Pharmaceuticals, Inc. is NASDAQ:ARWR

  • Does Arrowhead Pharmaceuticals, Inc. pay dividends?

    No, Arrowhead Pharmaceuticals, Inc. does not pay dividends

  • What sector is Arrowhead Pharmaceuticals, Inc. in?

    Arrowhead Pharmaceuticals, Inc. is in the Healthcare sector

  • What industry is Arrowhead Pharmaceuticals, Inc. in?

    Arrowhead Pharmaceuticals, Inc. is in the Biotechnology industry

  • What country is Arrowhead Pharmaceuticals, Inc. based in?

    Arrowhead Pharmaceuticals, Inc. is headquartered in United States

  • When did Arrowhead Pharmaceuticals, Inc. go public?

    Arrowhead Pharmaceuticals, Inc. initial public offering (IPO) was on December 16, 1993

  • Is Arrowhead Pharmaceuticals, Inc. in the S&P 500?

    No, Arrowhead Pharmaceuticals, Inc. is not included in the S&P 500 index

  • Is Arrowhead Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Arrowhead Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

  • Is Arrowhead Pharmaceuticals, Inc. in the Dow Jones?

    No, Arrowhead Pharmaceuticals, Inc. is not included in the Dow Jones index

  • When was Arrowhead Pharmaceuticals, Inc. last earnings report?

    Arrowhead Pharmaceuticals, Inc.'s most recent earnings report was on November 25, 2025

  • When does Arrowhead Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Arrowhead Pharmaceuticals, Inc. is February 9, 2026